Cognitive disorders in epilepsy I: Clinical experience, real-world evidence and recommendations.


Journal

Seizure
ISSN: 1532-2688
Titre abrégé: Seizure
Pays: England
ID NLM: 9306979

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 11 08 2020
revised: 02 10 2020
accepted: 04 10 2020
pubmed: 1 11 2020
medline: 5 1 2021
entrez: 31 10 2020
Statut: ppublish

Résumé

This is the first of two narrative reviews on cognitive disorders in epilepsy (companion publication : Cognitive disorders in epilepsy II: Clinical targets, indications and selection of test instruments). Its focus is on clinical experience, real-world evidence, and clinical recommendations. Cognitive disorders are a common comorbidity in children and adults with epilepsy. These cognitive disturbances may preceed the onset of seizures and are multifactorial including contributions by pre-existing brain damage, seizures, interictal epileptic discharges, and treatments including medications and surgery. Comorbid cognitive impairments can have a negative impact on the quality of life in people with epilepsy. They are under-identified and frequently not treated. Comorbid psychiatric disorders, such as ADHD can also contribute to a worse cognitive performance and can benefit from pharmacotherapy with CNS stimulants. Likewise, mood disorders cause a subjective perception of poor memory and attention, which can be reversed with antidepressants of the SSRI family. This narrative review discusses these issues from a real-world clinical perspective in children and adults with newly diagnosed and chronic epilepsy. The need for further research to understand and treat these disorders is noted.

Identifiants

pubmed: 33127274
pii: S1059-1311(20)30320-4
doi: 10.1016/j.seizure.2020.10.009
pii:
doi:

Substances chimiques

Anticonvulsants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

216-222

Informations de copyright

Copyright © 2020 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Auteurs

Andres M Kanner (AM)

Department of Neurology, Comprehensive Epilepsy Center, University of Miami, Miller School of Medicine, Miami, FL, USA. Electronic address: a.kanner@med.miami.edu.

Christoph Helmstaedter (C)

Department of Epileptology, University Hospital Bonn, Germany.

Zahra Sadat-Hossieny (Z)

Department of Neurology, Stanford Epilepsy Center, Stanford University School of Medicine, Palo Alto, CA, USA.

Kimford Meador (K)

Department of Neurology, Stanford Epilepsy Center, Stanford University School of Medicine, Palo Alto, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH